Between April 25 – May 8, 2020, 30 samples were checked using mass spectrometry technologies (gas- and liquid-chromatography). This report details the results from the analysis of those samples.

Between April 11 – 24, 2020, 21 samples were checked using mass spectrometry technologies (gas- and liquid-chromatography). This report details the results from the analysis of those samples.

Between October 10, 2019, when Toronto's drug checking service formally launched, and March 31, 2020, 543 samples were checked using mass spectrometry technologies (gas- and liquid-chromatography). This report details the results from the analysis of those samples.

Having emerged out of an international cross comparison of illegal drug policies conducted by the CDPE, the Drug Policy Metrics Map illuminates gaps and congruencies between the metrics that countries use to evaluate their drug policies, as well as the actual drug- and drug policy-related effects that those policies have on communities, as measured via data from the United Nations Office on Drugs and Crime.

As the Government of Ontario reviews the evidence on supervised consumption services, a new commentary in CMAJ calls for the continued operation of diverse service models and for future research to evaluate which models work best for different populations and settings, rather than the already answered question of whether supervised consumption is effective in reducing drug-related harms.

A Toronto-based drug policy research and communications group housed at St. Michael’s Hospital, a site of Unity Health Toronto, has unveiled its new identity.

The Centre on Drug Policy Evaluation (CDPE), formerly the International Centre for Science in Drug Policy (ICSDP), welcomes you to our new and improved website!

This resource aims to provide an overview of select drug checking services in Canada that are harmonizing research protocols and approaches for the purpose of ensuring nationwide comparability of collected evidence.

For the sixth consecutive year, a side event was held at the 61st Session of the Commission on Narcotic Drugs (CND) to continue the global discussion on reprioritizing the objectives and indicators used to evaluate drug policies.

Recommendations from a meeting of over 200 policymakers, public health officials, law enforcement professionals, researchers, people who use drugs, and community organizers provides an innovative roadmap to improve Canada’s policy response to illegal drugs over the coming ten years.